- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01716936
A Retrospective Review of Early Onset Spinal Deformity Patients Treated With the Ellipse MAGEC System
August 13, 2013 updated by: Ellipse Technologies, Inc.
A Retrospective Multicenter Review of Early Onset Spinal Deformity Patients That Underwent Either a Primary or Revision Spinal Bracing Procedure With the Ellipse Technologies MAGEC Spinal Bracing and Distraction System
The purpose of this study is to determine the safety profile and probable benefit of the Ellipse Technologies Inc. MAGEC System in subjects with early onset spinal deformity associated with thoracic insufficiency syndrome.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
54
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Cairo, Egypt, 11559
- University of Cairo Public Hospital
-
-
-
-
-
Helsinki, Finland, 00029
- University of Helsinki
-
Turku, Finland
- Turku University Hospital
-
-
-
-
-
Hong Kong, Hong Kong
- University of Hong Kong
-
-
-
-
-
Bologna, Italy
- Instituto Rizzoli
-
Rome, Italy
- Bambin Gesù
-
-
-
-
-
Auckland, New Zealand
- Starship Children's Hospital
-
-
-
-
-
Ankara, Turkey
- Hacettepe University Hospital
-
Ankara, Turkey
- Ankara Gazi Universitesi Hastanesi
-
Istanbul, Turkey, 34403
- Florence Nightingale Hospital Ortopedi Bolumu
-
Istanbul, Turkey
- Marmara Üniversitesi Eğt.ve Arş.Hastanesi
-
Izmir, Turkey
- Ege Sağlık Hastanesi
-
-
-
-
-
Cardiff, United Kingdom, CF 14 4XW
- University Hospital of Wales
-
London, United Kingdom
- The Harley Street Clinic
-
-
Middlesex
-
Stanmore, Middlesex, United Kingdom, HA7 4LP
- Royal National Orthopaedic Hospital NHS Trust
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 11 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
All patients worldwide implanted with the Ellipse Technologies Spinal Bracing and Distraction System (Invitation to Volunteer Non-Probability Sample).
Description
Inclusion Criteria:
- Early onset spinal deformity with any etiology
- Cobb angle measurement of 30 degrees or greater at the time of primary surgery
- Thoracic spine height (T1 to T12) less than 22 cm at the time of primary surgery
- Age less than 11 years old at the time of MAGEC implant
- Implanted with the MAGEC system as either a primary or secondary revision spinal bracing procedure
- Patient has been implanted for a minimum of 6 months
- Patient signs informed consent for the use of their personal private data
Exclusion Criteria:
- Patient declines to sign informed consent for the use of their personal private data.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
MAGEC Implant
All patients implanted with the MAGEC System will be reviewed for inclusion into this retrospective study.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Cobb Angle
Time Frame: Baseline and 6, 12, 18 and 24 Months Postoperatively
|
Measured in Degrees
|
Baseline and 6, 12, 18 and 24 Months Postoperatively
|
|
Change in Thoracic Spine Height
Time Frame: Baseline and 6, 12, 18 and 24 Months Postoperatively
|
Measured in millimeters (mm)
|
Baseline and 6, 12, 18 and 24 Months Postoperatively
|
|
Change in Space Available for Lung
Time Frame: Baseline and 6, 12, 18 and 24 Months Postoperatively
|
Measured as a percentage (%)
|
Baseline and 6, 12, 18 and 24 Months Postoperatively
|
|
Ocurrence of Procedure-Related Complications
Time Frame: Baseline, Device Implant and 6, 12, 18 and 24 Months Postoperatively
|
Baseline, Device Implant and 6, 12, 18 and 24 Months Postoperatively
|
|
|
Occurrence of Adverse Events
Time Frame: Baseline and 6, 12, 18 and 24 Months Postoperatively
|
Baseline and 6, 12, 18 and 24 Months Postoperatively
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Coronal Balance
Time Frame: Baseline and 6, 12, 18 and 24 Months Postoperatively
|
Measured in millimeters (mm)
|
Baseline and 6, 12, 18 and 24 Months Postoperatively
|
|
Change in Sagittal Balance
Time Frame: Baseline and 6, 12, 18 and 24 Months Postoperatively
|
Measured in millimeters (mm)
|
Baseline and 6, 12, 18 and 24 Months Postoperatively
|
|
Occurrence of Subsequent surgical interventions following initial implantation
Time Frame: Baseline and 6, 12, 18 and 24 Months Postoperatively
|
Baseline and 6, 12, 18 and 24 Months Postoperatively
|
|
|
Change in Weight
Time Frame: Baseline and 6, 12, 18 and 24 Months Postoperatively
|
Measured in kilograms (kg)
|
Baseline and 6, 12, 18 and 24 Months Postoperatively
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Behrooz A Akbarnia, MD, San Diego Center for Spinal Disorders
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2012
Primary Completion (Actual)
January 1, 2013
Study Completion (Actual)
January 1, 2013
Study Registration Dates
First Submitted
September 19, 2012
First Submitted That Met QC Criteria
October 26, 2012
First Posted (Estimate)
October 30, 2012
Study Record Updates
Last Update Posted (Estimate)
August 15, 2013
Last Update Submitted That Met QC Criteria
August 13, 2013
Last Verified
August 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PR0056
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Thoracic Insufficiency Syndrome
-
Vanderbilt University Medical CenterCompletedThoracic Insufficiency Syndrome (TIS)United States
-
Patrick Cahill, MDXemed LLCWithdrawnThoracic Insufficiency SyndromeUnited States
-
University of UtahWithdrawnThoracic Insufficiency Syndrome | TISUnited States
-
National Taiwan University HospitalUnknownVentilator-associated Lung Injury | Acute Pulmonary Insufficiency Following Thoracic SurgeryTaiwan
-
University of LeedsCompletedAdrenal; Insufficiency Gluccorticoid-Induced | Cushing; Syndrome or Disease, Glucocorticoid-Induced
-
University of ZurichJH Rahn Foundation, ZurichCompletedChronic Venous Insufficiency | Post-thrombotic SyndromeSwitzerland
-
Instituto Universitario de Oftalmobiología Aplicada...University of Valladolid; Red de Terapia Celular; Centro en Red de Medicina Regenerativa...CompletedLimbus Corneae Insufficiency SyndromeSpain
-
Qingyou MengActive, not recruitingThoracic Aortic Dissection | Thoracic Aortic DiseaseChina
-
First Affiliated Hospital Xi'an Jiaotong UniversityNot yet recruitingAcute Lung Injury/Acute Respiratory Distress Syndrome (ARDS) | Aortic DissectionChina
-
Zhujiang HospitalUnknownRenal Insufficiency, Chronic | Nephrotic SyndromeChina